Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology
Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen
Histone acetyltransferase (HAT) activation as a therapeutic strategy.... | Download Scientific Diagram
Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast and human cell lines - Huang - 2020 - Aging Cell - Wiley Online Library
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text
HAT inhibitors in cancer therapy - ScienceDirect
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
Histone deacetylase modulators provided by Mother Nature | Genes & Nutrition | Full Text
Cureus | Advances in Epigenetic Cancer Therapeutics
HAT inhibitors and activators, their target histone acetyltransferases,... | Download Table
Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo | Oncogenesis
Characterization of novel inhibitors of histone acetyltransferases | Molecular Cancer Therapeutics
HDAC and HAT activity toward DNA. HAT = histone acetyltransferase; HDAC... | Download Scientific Diagram
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry
